Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-28T04:17:17.162Z Has data issue: false hasContentIssue false

Chapter 3 - Neuroendocrinology of Female Reproduction

Published online by Cambridge University Press:  24 December 2018

Michael Wilkinson  and
S. Ali Imran
Michael Wilkinson
Affiliation:
Dalhousie University, Nova Scotia
S. Ali Imran
Affiliation:
Dalhousie University, Nova Scotia
Get access
Type
Chapter
Information
Clinical Neuroendocrinology
An Introduction
 , pp. 29 - 52
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Further Reading

Besser, G M & Thorner, M O. (2002). Comprehensive Clinical Endocrinology, 3rd Edition (St. Louis, MO: Mosby).Google Scholar
Boehm, U, Bouloux, P-M, Dattani, M T et al. (2015). European Consensus Statement on congenital hypogonadotropic hypogonadism – pathogenesis, diagnosis and treatment. Nat Revs Endocr 11, 547–564.Google Scholar
Caronia, L M, Martin, C, Welt, C K et al. (2011). A genetic basis for functional hypothalamic amenorrhea. N Engl J Med 364, 215–25.CrossRefGoogle ScholarPubMed
Christian, C A & Moenter, S M. (2010). The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges. Endocr Revs 31, 544–577.Google Scholar
Gordon, C M, Ackerman, K E, Berga, S L et al. (2017). Functional hypothalamic amenorrhea: An endocrine society clinical practice guideline. J Clin Endocr Metab 102, 1413–1439.CrossRefGoogle ScholarPubMed
Grumbach, M M. (2002). The neuroendocrinology of human puberty revisited. Horm Res 57 (Suppl 2), 2–14.Google Scholar
Hall, J E. (2014). Neuroendocrine control of the menstrual cycle. Yen and Jaffe’s Reproductive Endocrinology, 7th Edition; Strauss, J F & Barbieri, R L, Eds. (Philadelphia, PA: Elsevier), 141–156CrossRefGoogle Scholar
Herbison, A E. (2015). Physiology of the adult gonadotropin-releasing hormone neuronal network. Knobil and Neill’s Physiology of Reproduction, 4th Edition; Plant, T M & Zeleznik, A J, Eds. (New York: Elsevier), 399–467.Google Scholar
Pinilla, L, Aguilar, E, Dieguez, C, Millar, R P & Tena-Sempere, M. (2012). Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Revs 92, 1235–1316.CrossRefGoogle ScholarPubMed
Stamou, M I, Cox, K H & Crowley, W F Jr. (2015). Discovering genes essential to the hypothalamic regulation of human reproduction using a human disease model: Adjusting to life in the “-omics” era. Endocr Revs 36, 603–621.Google Scholar
Vuong, C, Van Uum, S H M, O’Dell, L E, Lutfy, K & Friedman, T C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Revs 31, 98–132.Google Scholar
Wierman, M E, Kiseljak-Vassiliades, K & Tobet, S. (2011). Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Fronts Neuroendocr 32, 43–52.CrossRefGoogle ScholarPubMed
Wilkinson, M & Brown, R E. (2015). An Introduction to Neuroendocrinology, 2nd Edition (Cambridge: Cambridge University Press).Google Scholar

References

Abbara, A, Jayasena, C N, Christopoulos, G et al. (2015). Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocr Metab 100, 3322–3331.Google Scholar
Abbara, A, Clarke, S, Islam, R et al. (2017). A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a phase 2 randomized controlled trial. Hum Reprod 32, 1915–1924Google Scholar
Abbara, A, Islam, R, Clarke, S A et al. (2018). Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different hormonal triggers of oocyte maturation in IVF treatment. Clin Endocr 88, 920–927.Google Scholar
Abs, R, Verhelst, J, Maeyaert, J et al. (2000). Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocr Metab 85, 2215–2222.Google Scholar
Ahmed, M I, Duleba, A J, El Shahat, O, Ibrahim, M E & Salem, A. (2008). Naltrexone treatment in clomiphene-resistant women with polycystic ovary syndrome. Human Reprod 23, 2564–2569.CrossRefGoogle ScholarPubMed
Antunes, J L, Carmel, P W, Housepian, E M & Ferin, M. (1978). Luteinizing hormone-releasing hormone in human pituitary blood. J Neurosurg 49, 382–386.Google Scholar
Azziz, R, Marin, C, Hoq, L, Badamgarav, E & Song, P. (2005). Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocr Metab 90, 4650–4658.Google Scholar
Balasubramanian, R, Dwyer, A, Seminara, S B, Pitteloud, N, Kaiser, U B & Crowley, W F Jr. (2010). Human GnRH deficiency: a unique disease model to unravel the ontogeny of GnRH neurons. Neuroendocr 92, 81–99.Google Scholar
Barbieri, R L. (2014). The endocrinology of the menstrual cycle. Methods Mol Biol 1154, 145–169.CrossRefGoogle ScholarPubMed
Belchetz, P E, Plant, T M, Nakai, Y, Keogh, E J & Knobil, E. (1978). Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202, 631–633.Google Scholar
Besser, G M & Thorner, M O. (2002). Comprehensive Clinical Endocrinology, 3rd Edition (St. Louis, MO: Mosby).Google Scholar
Bianco, S D & Kaiser, U B. (2009). The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocr 5, 569–576.Google Scholar
Boehm, U, Bouloux, P-M, Dattani, M T et al. (2015). European Consensus Statement on congenital hypogonadotropic hypogonadism – pathogenesis, diagnosis and treatment. Nat Revs Endocr 11, 547–564.CrossRefGoogle ScholarPubMed
Boron, W F & Boulpaep, E L. (2009). Medical Physiology, 2nd Edition (Philadelphia, PA: Elsevier Saunders).Google Scholar
Borsay, B A, Skrapits, K, Herczeg, L et al. (2014). Hypophysiotropic gonadotropin-releasing hormone projections are exposed to dense plexuses of kisspeptin, neurokinin B and substance P immunoreactive fibers in the human: a study on tissues from postmenopausal women. Neuroendocr 100, 141–152.Google Scholar
Boyar, R, Katz, J, Finkelstein, J W et al. (1974). Immaturity of 24-hour luteinizing hormone secretory pattern. New Engl J Med 291, 861–865.CrossRefGoogle ScholarPubMed
Brennan, M J. (2013). The effect of opioid therapy on endocrine function. Am J Med 126, S12–S18.Google Scholar
Brown, R E, Imran, S A, Ur, E & Wilkinson, M. (2008). KiSS-1 mRNA in adipose tissue is regulated by sex hormones and food intake. Mol Cell Endocr 281, 64–72.CrossRefGoogle ScholarPubMed
Cockwell, H, Wilkinson, DA, Bouzayen, R, Imran, S A, Brown, R & Wilkinson, M. (2013). KISS1 expression in human female adipose tissue. Arch Gynecol Obstet 287, 143–147.Google Scholar
Compton, W M, Jones, C M & Baldwin, G T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. New Engl J Med 374, 154–163.Google Scholar
Couzinet, B, Young, J, Brailly, S, Chanson, P & Schaison, G. (1995). Even after priming with ovarian steroids or pulsatile gonadotrophin releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. J Clin Endocr Metab 80, 2102–2107.Google ScholarPubMed
Daniell, H W. (2008). Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 9, 28–36.CrossRefGoogle ScholarPubMed
de Kretser, D M & O’Donnell, L. (2013). Endocrinology of the Male Reproductive System. www.endotext.orgGoogle Scholar
Delvigne, A & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8, 559–577.Google Scholar
Dhillo, W S, Chaudhri, O B, Thompson, E L et al. (2007). Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocr Metab 92, 3958–3966.Google Scholar
Dudas, B & Merchenthaler, I. (2001). Catecholaminergic axons innervate LH-releasing hormone immunoreactive neurons of the human diencephalon. J Clin Endocr Metab 86, 5620–5626.Google Scholar
Dudas, B & Merchenthaler, I. (2004). Close anatomical associations between β-endorphin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon. Neurosci 124, 221–229.CrossRefGoogle ScholarPubMed
Dudas, B & Merchenthaler, I. (2006). Three-dimensional representation of the neurotransmitter systems of the human hypothalamus: inputs of the gonadotrophin hormone-releasing hormone neuronal system. J Neuroendocr 18, 79–95.Google Scholar
Engel, J B & Schally, A V. (2007). Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Practice Endocr Metab 3, 157–167.Google Scholar
Eyvazzadeh, A D, Pennington, K P, Pop-Busui, R, Sowers, M, Zubieta, J-K & Smith, Y R. (2009). The role of the endogenous opioid system in polycystic ovary syndrome. Fertil Steril 92, 1–12.Google Scholar
Ferin, M, Wehrenberg, W B, Lam, N Y, Alston, E J & Vande Wiele, R L. (1982). Effects and site of action of morphine on gonadotropin secretion in the female rhesus monkey. Endocr 111, 1652–1656.Google Scholar
Filicori, M, Santoro, N, Merriam, G R & Crowley, W F Jr. (1986). Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocr Metab 62, 1136–1144.Google Scholar
Fraser, H M. (1993). GnRH analogues for contraception. Brit Med Bull 49, 62–72.Google Scholar
Fruzzetti, F, Bersi, C, Parrini, D, Ricci, C & Genazzani, AR. (2002). Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil Steril 77, 936–944.Google Scholar
Genazzani, AD, Gastaldi, M, Petraglia, F et al. (1995). Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. Human Reprod 10, 2868–2871.Google Scholar
Giusti, M, Delitala, G, Marini, G et al. (1992). The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol and thyroid stimulating hormone in healthy elderly men. Acta Endocr 127, 205–209.Google Scholar
Graves, G R, Kennedy, T G, Weick, R F & Casper, R F. (1993). The effect of nalmefene on pulsatile secretion of luteinizing hormone and prolactin in men. Hum Reprod 8, 1598–1603.Google Scholar
Grumbach, M M. (2002). The neuroendocrinology of human puberty revisited. Horm Res 57 (Suppl2), 2–14.Google Scholar
Hall, J E. (2014). Neuroendocrine control of the menstrual cycle. Yen and Jaffe’s Reproductive Endocrinology, 7th Edition. Strauss, J F & Barbieri, R L, Eds. (Philadelphia, PA: Elsevier), 141–156.Google Scholar
Harihar, S, Pounds, K M, Iwakuma, T, Seidah, N G & Welch, D R. (2015). Furin is the major proprotein convertase required for KISS1-to-kisspeptin processing. PLoS One 9, e84958.CrossRefGoogle Scholar
Herbison, A E. (2015). Physiology of the adult gonadotropin-releasing hormone neuronal network. Knobil and Neill’s Physiology of Reproduction, 4th Edition. Plant, T M & Zeleznik, A J, Eds. (New York: Elsevier), 399–467.Google Scholar
Herbison, A E. (2016). Control of puberty onset and fertility by gonadotropin-releasing hormone neurons. Nat Rev Endocr 12, 452–466.Google Scholar
Hrabovszky, E, Ciofi, P, Vida, B et al. (2010). The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Europ J Neurosci 31, 1984–1998.Google Scholar
Hrabovszky, E, Molnár, C S, Nagy, R et al. (2012). Glutamatergic and GABAergic innervation of human gonadotropin-releasing hormone-I neurons. Endocr 153, 2766–2776.Google Scholar
Hrabovszky, E & Liposits, Z. (2013). Afferent neuronal control of type-1 gonadotropin releasing hormone neurons in the human. Fronts Endocr 4, 1–19.Google Scholar
Hrabovszky, E. (2014). Neuroanatomy of the human hypothalamic kisspeptin system. Neuroendocr 99, 33–48.Google Scholar
Jayasena, C N, Nijher, G M K, Chaudhri, O B et al. (2009). Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocr Metab 94, 4315–4323.Google Scholar
Jayasena, C N, Comninos, A N, Veldhuis, J D et al. (2013). A single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy women. Clin Endocr 79, 558–563.Google Scholar
Jayasena, C N, Abbara, A, Veldhuis, J D et al. (2014). Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of kisspeptin-54. J Clin Endocr Metab 99, E953–E961.Google Scholar
Jayasena, C N, Abbara, A, Comninos, A N et al. (2014a). Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest 124, 3667–3677.Google Scholar
Jayasena, C N, Abbara, A, Narayanaswamy, S et al. (2015). Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men. Hum Reprod 30, 1934–1941.Google Scholar
Kapen, S, Boyar, R M, Finkelstein, J W, Hellman, L & Weitzman, E D. (1974). Effect of sleep-wake cycle reversal on luteinizing hormone secretory pattern in puberty. J Clin Endocr Metab 39, 293–299.Google Scholar
Katz, N & Mazer, N A. (2009). The impact of opioids on the endocrine system. Clin J Pain 25, 170–175.CrossRefGoogle ScholarPubMed
Khoury, S A, Reame, N E, Kelch, R P & Marshall, J C. (1987). Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an α2-adrenergic agonist. J Clin Endocr Metab 64, 755–762.Google Scholar
Knight, P J, Satchell, L & Glister, C. (2012). Intra-ovarian roles of activins and inhibins. Mol Cell Endocr 359,53–65.Google Scholar
Koons, A L, Rayl Greenberg, M, Cannon, R D & Beauchamp, G A. (2018). Women and the experience of pain and opioid use disorder: a literature-based commentary. Clin Therap 40, 190–196.Google Scholar
Krsmanovic, L Z, Hu, L, Leung, P-K, Feng, H & Catt, K J. (2009). The hypothalamic GnRH pulse generator: multiple regulatory mechanisms. Trends Endocr Metab 20, 402–408.Google Scholar
Lehman, M N, Coolen, L M & Goodman, R L. (2010). Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocr 151, 3479–3489.Google Scholar
Liu, J H, Patel, B & Collins, G. (2016). Central causes of amenorrhea. www.endotext.orgGoogle Scholar
McCarthy, M M. (2013). A piece in the puzzle of puberty. Nat Neurosci 16, 251–253.CrossRefGoogle ScholarPubMed
Meczekalski, B, Podfigurna-Stopa, A, Warenik-szymankiewicz, A & Genazzani, A R. (2008). Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocr 24, 4–11.CrossRefGoogle ScholarPubMed
Messager, S, Chatzidaki, E E, Ma, D et al. (2005). Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Nat Acad Sci USA 102, 1761–1766.Google Scholar
Messinis, I E, Messini, C I, & Dafopoulos, K. (2014). Novel aspects of the endocrinology of the menstrual cycle. Reprod Biomed Online 28, 714–722.Google Scholar
Millar, R P, Sonigo, C, Anderson, R A et al. (2017). Hypothalamic–pituitary–ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea. J Endocr Soc 1, 1362–1371.Google Scholar
Moenter, S M. (2015). Leap of faith: does serum luteinizing hormone always accurately reflect central reproductive neuroendocrine activity? Neuroendocr 102, 256–266.Google Scholar
Narayanaswamy, S, Jayasena, C N, Ng, N et al. (2015). Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels. Clin Endocr 84, 939–945.Google Scholar
Oakley, A E, Clifton, D K & Steiner, R A. (2009). Kisspeptin signaling in the brain. Endocr Rev 30, 713–743.Google Scholar
Padmanabhan, V. (2009). Polycystic ovary syndrome – “a riddle wrapped in a mystery inside an enigma”. J Clin Endocr Metab 94, 1883–1885.Google Scholar
Peckys, D & Landwehrmeyer, G B. (1999). Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neurosci 88, 1093–1135.Google Scholar
Petraglia, F, Degli Uberti, E C, Trasforini, G et al. (1985). Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. Peptides 6, 869–72.Google Scholar
Pinilla, L, Aguilar, E, Dieguez, C, Millar, R P & Tena-Sempere, M. (2012). Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Revs 92, 1235–1316.Google Scholar
Prague, J K & Dhillo, W S. (2015). Potential clinical use of kisspeptin. Neuroendocr 102, 238–245.Google Scholar
Prague, J K, Roberts, R E, Comninos, A N et al. (2017). Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 389, 1809–1820.Google Scholar
Rabin, D & McNeil, L W. (1980). Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocr Metab 51, 873–876.Google Scholar
Rance, N E. (2009). Menopause and the human hypothalamus: Evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 30, 111–122.Google Scholar
Rasmussen, D D, Gambacciani, M, Swartz, W, Tueros, V S & Yen, S S. (1989). Pulsatile gonadotropin-releasing hormone release from the human mediobasal hypothalamus in vitro: opiate receptor-mediated suppression. Neuroendocr 49, 150–156.Google Scholar
Reed, B J & Carr, B R. (2015). The normal menstrual cycle and the control of ovulation. www.endotext.orgGoogle Scholar
Reid, R L, Hoff, J D, Yen, S S & Li, C H. (1981). Effects of exogenous beta-endorphin on pituitary hormone secretion and its disappearance in normal human subjects. J Clin Endocr Metab 52, 1179–1184.Google Scholar
Rhodin, A, Stridsberg, M & Gord, T. (2010). Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 26, 373–380.CrossRefGoogle ScholarPubMed
Roa, J, Aguilar, E, Dieguez, C, Pinilla, L & Tena-Sempere, M. (2008). New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocr 29, 48–69.Google Scholar
Robertson, D M. (2012). Inhibins and activins in blood: predictors of female reproductive health? Mol Cell Endocr 34, 78–84.Google Scholar
Robertson, D M, Hale, G E, Jolley, D, Fraser, I S, Hughes, C L & Burger, H G. (2009). Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J Clin Endocr Metab 94, 138–144.Google Scholar
Roche, D J O & King, A C. (2015). Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase. Psychoneuroendocr 52, 59–71.Google Scholar
Rometo, A M & Rance, N E. (2008). Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women. J Neuroendocr 20, 1376–1381.Google Scholar
Roozenburg, B J, van Dessel, H J H M, Evers, J L H & Bots, R S M. (1997). Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment. Human Reprod 12, 1720–1722.Google Scholar
Rossmanith, W G, Wirth, U, Sterzik, K & Yen, S S. (1989). The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle. J Endocr Invest 12, 245–252.Google Scholar
Schmittner, J, Schroeder, J R, Epstein, D H & Preston, K L. (2005). Menstrual cycle length during methadone maintenance. Addiction 100, 829–836.Google Scholar
Semple, R K & Topaloglu, A K. (2010). Neurokinin B and its receptor in hypogonadotropic hypogonadism. Front Horm Res 39, 133–141.CrossRefGoogle ScholarPubMed
Shaw, N D, Butler, J P, McKinney, S M, Nelson, S A, Ellenbogen, J M & Hall, J E. (2012). Insights into puberty: the relationship between sleep stages and pulsatile LH secretion. J Clin Endocr Metab 97, E2055–E2062.Google Scholar
Silveira, L F G & Latronico, A C. (2013). Approach to the patient with hypogonadotropic hypogonadism. J Clin Endocr Metab 98, 1781–1788.Google Scholar
Silveira, L G, Latronico, A C & Seminara, S B. (2013). Kisspeptin and clinical disorders. Adv Exp Med Biol 784, 187–199.Google Scholar
Skinner, D C, Albertson, A J, Navratil, A et al. (2009). Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis. J Neuroendocr 21, 282–292.Google Scholar
Skorupskaite, K, George, J T & Anderson, R A. (2014). The kisspeptin–GnRH pathway in human reproductive health and disease. Human Reprod Update 20, 485–500.Google Scholar
Skorupskaite, K, George, J T, Veldhuis, J D & Anderson, R A. (2018a). Neurokinin B regulates gonadotropin secretion, ovarian follicle growth, and the timing of ovulation in healthy women. J Clin Endocr Metab 103, 95–104.Google Scholar
Skorupskaite, K, George, J T, Veldhuis, J D, Millar, R P & Anderson, R A. (2018b). Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women. Neuroendocr 106, 148–157.CrossRefGoogle ScholarPubMed
Skrapits, K, Kanti, V, Savanyú, Z et al. (2015). Lateral hypothalamic orexin and melanin-concentrating hormone neurons provide direct input to gonadotropin-releasing hormone neurons in the human. Fronts Cellular Neurosci 9, 1–13.Google Scholar
Southworth, M B, Matsumoto, A M, Gross, K M, Soules, M R & Bremner, W J. (1991). The importance of signal pattern in the transmission of endocrine information: pituitary gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone. J Clin Endocr Metab 72, 1286–1289.Google Scholar
Stamou, M I, Cox, K H & Crowley, W F Jr. (2015). Discovering genes essential to the hypothalamic regulation of human reproduction using a human disease model: adjusting to life in the “-omics” era. Endocr Revs 36, 603–621.Google Scholar
Stamou, M I & Georgopoulos, N A. (2017). Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metab 86, 124–134.Google Scholar
Taziaux, M, Staphorsius, A S, Ghatei, M A, Bloom, S R, Swaab, D F & Bakker, J. (2016). Kisspeptin expression in the human infundibular nucleus in relation to sex, gender identity, and sexual orientation. J Clin Endocr Metab 101, 2380–2389.Google Scholar
Teles, M, Bianco, S D, Brito, V N et al. (2008). A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358, 709–715.Google Scholar
Tenhola, H, Sinclair, D, Alho, H & Lahti, T. (2012). Effect of opioid antagonists on sex hormone secretion. J Endocr Invest 35, 227–230.Google Scholar
Teoh, S K, Mendelson, J H, Mello, N K & Skupny, A. (1988). Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle. J Clin Endocr Metab 66, 1181–1186.CrossRefGoogle ScholarPubMed
Thomsen, L & Humaidan, P. (2015). Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin. Curr Opin Obst Gynecol 27, 210–214.Google Scholar
Valdes-Socin, H, Almanza, M R, Fernández-Ladreda, M T, Debray, F G, Bours, V & Beckers, A. (2014). Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Fronts Endocr 5, 1–8.Google Scholar
Vuong, C, Van Uum, S H M, O’Dell, L E, Lutfy, K & Friedman, T C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Revs 31, 98–132.Google Scholar
Wahab, F, Atika, B, Shahab, M & Behr, R. (2016). Kisspeptin signalling in the physiology and pathophysiology of the urogenital system. Nat Revs Urol 13, 21–32.CrossRefGoogle ScholarPubMed
Wildt, L, Leyendecker, G, Sir-Petermann, T & Waibel-Treber, S. (1993). Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Human Reprod 8, 350–358.Google Scholar
Wilkinson, M & Brown, R E. (2015). An Introduction to Neuroendocrinology, 2nd Edition (Cambridge: Cambridge University Press).Google Scholar
Williams, C L, Nishihara, M, Thalabard, J C et al. (1990). Duration and frequency of multiunit electrical activity associated with the hypothalamic gonadotropin releasing hormone pulse generator in the rhesus monkey: differential effects of morphine. Neuroendocr 52, 225–228.Google Scholar
Zatelli, M C, Ambrosio, M R, Bondanelli, M & degli Uberti, E. (2014). Pituitary side effects of old and new drugs. J Endocr Invest 37, 917–923.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×